Ascendis Pharma As Stock Price History
| ASND Stock | USD 163.24 2.81 1.69% |
Below is the normalized historical share price chart for Ascendis Pharma AS extending back to January 28, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Ascendis Pharma stands at 163.24, as last reported on the 20th of March, with the highest price reaching 166.86 and the lowest price hitting 161.01 during the day.
If you're considering investing in Ascendis Stock, it is important to understand the factors that can impact its price. Ascendis Pharma appears to be very steady, given 3 months investment horizon. Ascendis Pharma AS secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11 % return per unit of standard deviation over the last 3 months. We have found thirty technical indicators for Ascendis Pharma AS, which you can use to evaluate the volatility of the firm. Please makes use of Ascendis Pharma's risk adjusted performance of 0.1059, and Mean Deviation of 2.5 to double-check if our risk estimates are consistent with your expectations.
At present, Ascendis Pharma's Stock Based Compensation is projected to increase significantly based on the last few years of reporting. Sale Purchase Of Stock is expected to grow at the current pace this year, whereas Common Stock Total Equity is forecasted to decline to about 4.2 M. . The current year's Price Earnings To Growth Ratio is expected to grow to 0.92, whereas Price To Sales Ratio is forecasted to decline to 19.92. Ascendis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 28th of January 2015 | 200 Day MA 134.8966 | 50 Day MA 140.146 | Beta 0.612 |
Ascendis |
Sharpe Ratio = 0.112
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ASND | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.44 actual daily | 30 70% of assets are more volatile |
Expected Return
| 0.38 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Ascendis Pharma is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ascendis Pharma by adding it to a well-diversified portfolio.
Price Book 14.5547 | Enterprise Value Ebitda (20.75) | Price Sales 27.4392 | Shares Float 59.4 M | Wall Street Target Price 211.4104 |
Ascendis Pharma Stock Price History Chart
There are several ways to analyze Ascendis Stock price data. The simplest method is using a basic Ascendis candlestick price chart, which shows Ascendis Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | March 17, 2025 | 168.84 |
| Lowest Price | February 10, 2025 | 119.49 |
Ascendis Pharma March 20, 2025 Stock Price Synopsis
Various analyses of Ascendis Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Ascendis Stock. It can be used to describe the percentage change in the price of Ascendis Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Ascendis Stock.| Ascendis Pharma Price Action Indicator | (2.10) | |
| Ascendis Pharma Price Daily Balance Of Power | (0.48) | |
| Ascendis Pharma Price Rate Of Daily Change | 0.98 |
Ascendis Pharma March 20, 2025 Stock Price Analysis
Ascendis Stock Price History Data
The price series of Ascendis Pharma for the period between Fri, Dec 20, 2024 and Thu, Mar 20, 2025 has a statistical range of 49.35 with a coefficient of variation of 8.6. The prices are distributed with arithmetic mean of 139.36. The median price for the last 90 days is 137.67.| Open | High | Low | Close | Volume | ||
03/20/2025 | 166.05 | 166.86 | 161.01 | 163.24 | ||
| 03/19/2025 | 164.29 | 166.86 | 161.01 | 166.05 | 315,572 | |
| 03/18/2025 | 168.01 | 168.97 | 163.93 | 164.65 | 393,036 | |
| 03/17/2025 | 157.90 | 169.37 | 157.59 | 168.84 | 1,117,191 | |
| 03/14/2025 | 153.00 | 155.39 | 151.22 | 152.98 | 405,736 | |
| 03/13/2025 | 150.20 | 153.50 | 148.57 | 152.31 | 425,117 | |
| 03/12/2025 | 147.64 | 150.80 | 146.05 | 150.31 | 465,903 | |
| 03/11/2025 | 137.90 | 145.97 | 136.57 | 145.63 | 397,025 | |
| 03/10/2025 | 143.70 | 144.12 | 137.02 | 138.18 | 458,429 | |
| 03/07/2025 | 151.03 | 152.41 | 144.75 | 145.74 | 350,980 | |
| 03/06/2025 | 154.32 | 155.39 | 149.35 | 151.51 | 409,933 | |
| 03/05/2025 | 150.15 | 155.98 | 146.23 | 155.86 | 861,353 | |
| 03/04/2025 | 150.55 | 152.33 | 147.30 | 150.81 | 424,398 | |
| 03/03/2025 | 157.78 | 158.00 | 150.95 | 151.93 | 581,907 | |
| 02/28/2025 | 153.00 | 157.49 | 153.00 | 156.58 | 429,232 | |
| 02/27/2025 | 152.50 | 155.04 | 152.17 | 153.14 | 239,847 | |
| 02/26/2025 | 151.56 | 155.99 | 148.18 | 152.61 | 527,158 | |
| 02/25/2025 | 151.94 | 152.78 | 148.02 | 151.53 | 414,939 | |
| 02/24/2025 | 152.43 | 153.84 | 150.08 | 151.06 | 269,143 | |
| 02/21/2025 | 153.65 | 155.45 | 151.96 | 152.43 | 444,151 | |
| 02/20/2025 | 153.14 | 156.09 | 151.59 | 154.58 | 472,867 | |
| 02/19/2025 | 154.90 | 156.69 | 150.09 | 155.11 | 803,905 | |
| 02/18/2025 | 145.48 | 157.37 | 145.00 | 156.19 | 924,708 | |
| 02/14/2025 | 142.85 | 146.91 | 141.82 | 144.08 | 551,280 | |
| 02/13/2025 | 138.75 | 147.68 | 137.87 | 142.49 | 1,501,932 | |
| 02/12/2025 | 118.50 | 127.62 | 118.03 | 126.14 | 838,892 | |
| 02/11/2025 | 118.22 | 120.58 | 118.22 | 119.51 | 572,612 | |
| 02/10/2025 | 121.45 | 122.73 | 119.02 | 119.49 | 274,036 | |
| 02/07/2025 | 124.46 | 126.33 | 120.46 | 120.87 | 414,515 | |
| 02/06/2025 | 127.65 | 130.69 | 125.00 | 125.02 | 475,420 | |
| 02/05/2025 | 122.80 | 131.65 | 120.54 | 129.41 | 668,286 | |
| 02/04/2025 | 125.13 | 127.00 | 122.05 | 122.25 | 444,956 | |
| 02/03/2025 | 127.01 | 130.30 | 124.37 | 125.09 | 250,856 | |
| 01/31/2025 | 127.59 | 132.06 | 127.59 | 130.66 | 365,497 | |
| 01/30/2025 | 128.37 | 129.62 | 125.41 | 127.30 | 194,548 | |
| 01/29/2025 | 129.94 | 131.22 | 125.23 | 127.55 | 195,371 | |
| 01/28/2025 | 126.68 | 130.44 | 125.00 | 129.37 | 203,490 | |
| 01/27/2025 | 127.90 | 129.54 | 124.69 | 126.05 | 563,591 | |
| 01/24/2025 | 127.54 | 131.06 | 126.45 | 128.20 | 473,687 | |
| 01/23/2025 | 126.05 | 129.38 | 122.52 | 127.49 | 829,776 | |
| 01/22/2025 | 131.45 | 131.70 | 123.02 | 125.82 | 551,934 | |
| 01/21/2025 | 128.55 | 131.57 | 126.37 | 131.06 | 631,765 | |
| 01/17/2025 | 131.57 | 133.38 | 127.60 | 128.13 | 359,329 | |
| 01/16/2025 | 134.73 | 135.42 | 126.38 | 131.62 | 402,701 | |
| 01/15/2025 | 133.60 | 137.29 | 132.72 | 134.87 | 261,100 | |
| 01/14/2025 | 135.30 | 137.54 | 130.97 | 131.57 | 462,422 | |
| 01/13/2025 | 127.63 | 136.88 | 127.63 | 134.04 | 720,421 | |
| 01/10/2025 | 132.70 | 135.17 | 127.27 | 129.19 | 618,237 | |
| 01/08/2025 | 136.48 | 138.65 | 133.82 | 134.43 | 500,336 | |
| 01/07/2025 | 141.99 | 141.99 | 136.07 | 137.29 | 393,390 | |
| 01/06/2025 | 140.77 | 141.48 | 136.73 | 140.28 | 480,734 | |
| 01/03/2025 | 137.50 | 140.99 | 137.50 | 140.40 | 314,489 | |
| 01/02/2025 | 137.77 | 140.74 | 136.60 | 138.00 | 316,132 | |
| 12/31/2024 | 138.00 | 138.00 | 134.71 | 137.67 | 244,725 | |
| 12/30/2024 | 136.33 | 138.47 | 134.50 | 136.48 | 188,762 | |
| 12/27/2024 | 139.39 | 141.25 | 137.26 | 137.50 | 164,618 | |
| 12/26/2024 | 138.45 | 141.47 | 136.90 | 140.31 | 119,900 | |
| 12/24/2024 | 139.70 | 140.22 | 136.34 | 138.79 | 72,154 | |
| 12/23/2024 | 137.28 | 140.47 | 135.61 | 139.70 | 157,641 | |
| 12/20/2024 | 137.00 | 141.37 | 135.61 | 136.38 | 690,269 | |
| 12/19/2024 | 136.53 | 139.39 | 134.53 | 137.74 | 576,030 |
About Ascendis Pharma Stock history
Ascendis Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ascendis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ascendis Pharma AS will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ascendis Pharma stock prices may prove useful in developing a viable investing in Ascendis Pharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 57.3 M | 41.1 M | |
| Net Loss | -524.9 M | -498.6 M |
Ascendis Pharma Stock Technical Analysis
Ascendis Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
| All Next | Launch Module |
Ascendis Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Ascendis Pharma's price direction in advance. Along with the technical and fundamental analysis of Ascendis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ascendis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1059 | |||
| Jensen Alpha | 0.4506 | |||
| Total Risk Alpha | 0.6547 | |||
| Sortino Ratio | 0.1766 | |||
| Treynor Ratio | 0.3313 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Ascendis Stock analysis
When running Ascendis Pharma's price analysis, check to measure Ascendis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascendis Pharma is operating at the current time. Most of Ascendis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascendis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascendis Pharma's price. Additionally, you may evaluate how the addition of Ascendis Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |